Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3).

Zingg W, Storr J, Park BJ, Jernigan JA, Harbarth S, Grayson ML, Tacconelli E, Allegranzi B, Cardo D, Pittet D; 2017 Geneva-IPC Think Tank.

Antimicrob Resist Infect Control. 2019 May 10;8:74. doi: 10.1186/s13756-019-0528-0. eCollection 2019.

2.

Surgical site infection risk following cesarean deliveries covered by Medicaid or private insurance.

Yi SH, Perkins KM, Kazakova SV, Hatfield KM, Kleinbaum DG, Baggs J, Slayton RB, Jernigan JA.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):639-648. doi: 10.1017/ice.2019.66. Epub 2019 Apr 9.

PMID:
30963987
3.

Modeling regional transmission and containment of a healthcare-associated multidrug-resistant organism.

Paul P, Slayton RB, Kallen AJ, Walters MS, Jernigan JA.

Clin Infect Dis. 2019 Mar 28. pii: ciz248. doi: 10.1093/cid/ciz248. [Epub ahead of print]

PMID:
30919885
4.

Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.

Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Heim L, Gombosev A, Avery TR, Haffenreffer K, Shimelman L, Hayden MK, Weinstein RA, Spencer-Smith C, Kaganov RE, Murphy MV, Forehand T, Lankiewicz J, Coady MH, Portillo L, Sarup-Patel J, Jernigan JA, Perlin JB, Platt R; ABATE Infection trial team.

Lancet. 2019 Mar 23;393(10177):1205-1215. doi: 10.1016/S0140-6736(18)32593-5. Epub 2019 Mar 5. Erratum in: Lancet. 2019 Mar 23;393(10177):1204.

PMID:
30850112
5.

Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers - United States, 2005-2017.

Jones M, Jernigan JA, Evans ME, Roselle GA, Hatfield KM, Samore MH.

MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):220-224. doi: 10.15585/mmwr.mm6809e2.

6.

Association between Antibiotic Use and Hospital-Onset Clostridioidesdifficile Infection in U.S. Acute Care Hospitals, 2006-2012: an Ecologic Analysis.

Kazakova SV, Baggs J, McDonald LC, Yi SH, Hatfield KM, Guh A, Reddy SC, Jernigan JA.

Clin Infect Dis. 2019 Mar 1. pii: ciz169. doi: 10.1093/cid/ciz169. [Epub ahead of print]

PMID:
30820545
7.

Things We Do For Good Reasons: Contact Precautions for Multidrug-resistant Organisms, Including MRSA and VRE.

Maragakis LL, Jernigan JA.

J Hosp Med. 2019 Mar;14(3):194-196. doi: 10.12788/jhm.3169. No abstract available.

PMID:
30811332
8.

Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.

Huang SS, Singh R, McKinnell JA, Park S, Gombosev A, Eells SJ, Gillen DL, Kim D, Rashid S, Macias-Gil R, Bolaris MA, Tjoa T, Cao C, Hong SS, Lequieu J, Cui E, Chang J, He J, Evans K, Peterson E, Simpson G, Robinson P, Choi C, Bailey CC Jr, Leo JD, Amin A, Goldmann D, Jernigan JA, Platt R, Septimus E, Weinstein RA, Hayden MK, Miller LG; Project CLEAR Trial.

N Engl J Med. 2019 Feb 14;380(7):638-650. doi: 10.1056/NEJMoa1716771.

PMID:
30763195
9.

The SHIELD Orange County Project -Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California.

McKinnell JA, Singh RD, Miller LG, Kleinman K, Gussin G, He J, Saavedra R, Dutciuc TD, Estevez M, Chang J, Heim L, Yamaguchi S, Custodio H, Gohil SK, Park S, Tam S, Robinson PA, Tjoa T, Nguyen J, Evans KD, Bittencourt CE, Lee BY, Mueller LE, Bartsch SM, Jernigan JA, Slayton RB, Stone ND, Zahn M, Mor V, McConeghy K, Baier RR, Janssen L, O'Donnell K, Weinstein RA, Hayden MK, Coady MH, Bhattarai M, Peterson EM, Huang SS; CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program.

Clin Infect Dis. 2019 Feb 11. doi: 10.1093/cid/ciz119. [Epub ahead of print]

PMID:
30753383
10.

Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals.

Scott RD 2nd, Slayton RB, Lessa FC, Baggs J, Culler SD, McDonald LC, Jernigan JA.

Antimicrob Resist Infect Control. 2019 Jan 22;8:17. doi: 10.1186/s13756-018-0459-1. eCollection 2019.

11.

Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons.

Rhee C, Jentzsch MS, Kadri SS, Seymour CW, Angus DC, Murphy DJ, Martin GS, Dantes RB, Epstein L, Fiore AE, Jernigan JA, Danner RL, Warren DK, Septimus EJ, Hickok J, Poland RE, Jin R, Fram D, Schaaf R, Wang R, Klompas M; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program.

Crit Care Med. 2019 Apr;47(4):493-500. doi: 10.1097/CCM.0000000000003554.

PMID:
30431493
12.

Trends in antifungal use in US hospitals, 2006-12.

Vallabhaneni S, Baggs J, Tsay S, Srinivasan AR, Jernigan JA, Jackson BR.

J Antimicrob Chemother. 2018 Oct 1;73(10):2867-2875. doi: 10.1093/jac/dky270.

PMID:
30295769
13.

Assessing Variability in Hospital-Level Mortality Among U.S. Medicare Beneficiaries With Hospitalizations for Severe Sepsis and Septic Shock.

Hatfield KM, Dantes RB, Baggs J, Sapiano MRP, Fiore AE, Jernigan JA, Epstein L.

Crit Care Med. 2018 Nov;46(11):1753-1760. doi: 10.1097/CCM.0000000000003324.

PMID:
30024430
14.

Reply to Dinh et al.

Yi SH, Hatfield KM, Baggs J, Hicks LA, Srinivasan A, Reddy S, Jernigan JA.

Clin Infect Dis. 2018 Jun 1;66(12):1982-1983. doi: 10.1093/cid/ciy049. No abstract available.

PMID:
29370360
15.

Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure.

Baggs J, Jernigan JA, Halpin AL, Epstein L, Hatfield KM, McDonald LC.

Clin Infect Dis. 2018 Mar 19;66(7):1004-1012. doi: 10.1093/cid/cix947.

PMID:
29136126
16.

Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States.

Yi SH, Hatfield KM, Baggs J, Hicks LA, Srinivasan A, Reddy S, Jernigan JA.

Clin Infect Dis. 2018 Apr 17;66(9):1333-1341. doi: 10.1093/cid/cix986.

17.

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, Kadri SS, Angus DC, Danner RL, Fiore AE, Jernigan JA, Martin GS, Septimus E, Warren DK, Karcz A, Chan C, Menchaca JT, Wang R, Gruber S, Klompas M; CDC Prevention Epicenter Program.

JAMA. 2017 Oct 3;318(13):1241-1249. doi: 10.1001/jama.2017.13836.

18.

Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus.

Nelson RE, Slayton RB, Stevens VW, Jones MM, Khader K, Rubin MA, Jernigan JA, Samore MH.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):848-856. doi: 10.1017/ice.2017.83. Epub 2017 Jun 1.

PMID:
28566096
19.

The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.

Toth DJA, Khader K, Slayton RB, Kallen AJ, Gundlapalli AV, O'Hagan JJ, Fiore AE, Rubin MA, Jernigan JA, Samore MH.

Clin Infect Dis. 2017 Aug 15;65(4):581-587. doi: 10.1093/cid/cix370.

PMID:
28472233
20.

Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel.

Alraddadi BM, Al-Salmi HS, Jacobs-Slifka K, Slayton RB, Estivariz CF, Geller AI, Al-Turkistani HH, Al-Rehily SS, Alserehi HA, Wali GY, Alshukairi AN, Azhar EI, Haynes L, Swerdlow DL, Jernigan JA, Madani TA.

Emerg Infect Dis. 2016 Nov;22(11):1915-1920. doi: 10.3201/eid2211.160920.

21.

Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012.

Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA.

JAMA Intern Med. 2016 Nov 1;176(11):1639-1648. doi: 10.1001/jamainternmed.2016.5651.

PMID:
27653796
22.

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Bartsch SM, Huang SS, Wong KF, Slayton RB, McKinnell JA, Sahm DF, Kazmierczak K, Mueller LE, Jernigan JA, Lee BY.

J Clin Microbiol. 2016 Nov;54(11):2757-2762. Epub 2016 Aug 31.

23.

Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention.

Novosad SA, Sapiano MR, Grigg C, Lake J, Robyn M, Dumyati G, Felsen C, Blog D, Dufort E, Zansky S, Wiedeman K, Avery L, Dantes RB, Jernigan JA, Magill SS, Fiore A, Epstein L.

MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):864-9. doi: 10.15585/mmwr.mm6533e1.

24.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Peterson K, Clifford McDonald L.

Am J Transplant. 2016 Jul;16(7):2224-30. doi: 10.1111/ajt.13893.

25.

Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014.

Hastings DL, Tokars JI, Abdel Aziz IZ, Alkhaldi KZ, Bensadek AT, Alraddadi BM, Jokhdar H, Jernigan JA, Garout MA, Tomczyk SM, Oboho IK, Geller AI, Arinaminpathy N, Swerdlow DL, Madani TA.

Emerg Infect Dis. 2016 May;22(5):794-801. doi: 10.3201/eid2205.151797.

26.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Peterson K, McDonald LC.

MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):235-41. doi: 10.15585/mmwr.mm6509e1.

27.

Sustained Infection Reduction in Outpatient Hemodialysis Centers Participating in a Collaborative Bloodstream Infection Prevention Effort.

Yi SH, Kallen AJ, Hess S, Bren VR, Lincoln ME, Downham G, Kelley K, Booth SL, Weirich H, Shugart A, Lines C, Melville A, Jernigan JA, Kleinbaum DG, Patel PR.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):863-6. doi: 10.1017/ice.2016.22. Epub 2016 Feb 12.

PMID:
26868605
28.

The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao C, Kim DS, Kallen AJ, Jernigan JA, Huang SS.

Am J Epidemiol. 2016 Mar 1;183(5):471-9. doi: 10.1093/aje/kwv299. Epub 2016 Feb 8.

29.

Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals.

Yi SH, Jernigan JA, McDonald LC.

Am J Infect Control. 2016 May 1;44(5):548-53. doi: 10.1016/j.ajic.2015.12.001. Epub 2016 Jan 25.

PMID:
26822808
30.

Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial.

Huang SS, Septimus E, Hayden MK, Kleinman K, Sturtevant J, Avery TR, Moody J, Hickok J, Lankiewicz J, Gombosev A, Kaganov RE, Haffenreffer K, Jernigan JA, Perlin JB, Platt R, Weinstein RA; Agency for Healthcare Research and Quality (AHRQ) DEcIDE Network and Healthcare-Associated Infections Program, and the CDC Prevention Epicenters Program.

Lancet Infect Dis. 2016 Jan;16(1):70-79. doi: 10.1016/S1473-3099(15)00238-8. Epub 2015 Nov 27.

31.

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.

Slayton RB, Toth D, Lee BY, Tanner W, Bartsch SM, Khader K, Wong K, Brown K, McKinnell JA, Ray W, Miller LG, Rubin M, Kim DS, Adler F, Cao C, Avery L, Stone NT, Kallen A, Samore M, Huang SS, Fridkin S, Jernigan JA.

MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31.

32.

The Likelihood of Hospital Readmission Among Patients With Hospital-Onset Central Line-Associated Bloodstream Infections.

Khong CJ, Baggs J, Kleinbaum D, Cochran R, Jernigan JA.

Infect Control Hosp Epidemiol. 2015 Aug;36(8):886-92. doi: 10.1017/ice.2015.115. Epub 2015 May 20.

33.

The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program.

Slayton RB, Scott RD, Baggs J, Lessa FC, McDonald LC, Jernigan JA.

Infect Control Hosp Epidemiol. 2015 Jun;36(6):681-7. doi: 10.1017/ice.2015.43. Epub 2015 Mar 18.

34.

Systems for rapidly detecting and treating persons with ebola virus disease--United States.

Koonin LM, Jamieson DJ, Jernigan JA, Van Beneden CA, Kosmos C, Harvey MC, Pietz H, Bertolli J, Perz JF, Whitney CG, Halpin AS, Daley WR, Pesik N, Margolis GS, Tumpey A, Tappero J, Damon I; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Mar 6;64(8):222-5.

35.

Medicare Reimbursement Attributable to Periprosthetic Joint Infection Following Primary Hip and Knee Arthroplasty.

Yi SH, Baggs J, Culler SD, BerrĂ­os-Torres SI, Jernigan JA.

J Arthroplasty. 2015 Jun;30(6):931-8.e2. doi: 10.1016/j.arth.2015.01.017. Epub 2015 Jan 19.

PMID:
25727999
36.

A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.

Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle LE, Salgado CD, Bryant K, Classen D, Crist K, Deloney VM, Fishman NO, Foster N, Goldmann DA, Humphreys E, Jernigan JA, Padberg J, Perl TM, Podgorny K, Septimus EJ, VanAmringe M, Weaver T, Weinstein RA, Wise R, Maragakis LL.

Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S21-31.

PMID:
25376067
37.

Does chlorhexidine bathing in adult intensive care units reduce blood culture contamination? A pragmatic cluster-randomized trial.

Septimus EJ, Hayden MK, Kleinman K, Avery TR, Moody J, Weinstein RA, Hickok J, Lankiewicz J, Gombosev A, Haffenreffer K, Kaganov RE, Jernigan JA, Perlin JB, Platt R, Huang SS.

Infect Control Hosp Epidemiol. 2014 Oct;35 Suppl 3:S17-22. doi: 10.1086/677822.

PMID:
25222893
38.

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates.

Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle LE, Salgado CD, Bryant K, Classen D, Crist K, Deloney VM, Fishman NO, Foster N, Goldmann DA, Humphreys E, Jernigan JA, Padberg J, Perl TM, Podgorny K, Septimus EJ, VanAmringe M, Weaver T, Weinstein RA, Wise R, Maragakis LL.

Am J Infect Control. 2014 Aug;42(8):820-8. doi: 10.1016/j.ajic.2014.07.002.

PMID:
25087135
39.

A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.

Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle LE, Salgado CD, Bryant K, Classen D, Crist K, Deloney VM, Fishman NO, Foster N, Goldmann DA, Humphreys E, Jernigan JA, Padberg J, Perl TM, Podgorny K, Septimus EJ, VanAmringe M, Weaver T, Weinstein RA, Wise R, Maragakis LL; Society for Healthcare Epidemiology of America (SHEA).

Infect Control Hosp Epidemiol. 2014 Aug;35(8):967-77. doi: 10.1086/677216.

40.

CDC central-line bloodstream infection prevention efforts produced net benefits of at least $640 Million during 1990-2008.

Scott RD 2nd, Sinkowitz-Cochran R, Wise ME, Baggs J, Goates S, Solomon SL, McDonald LC, Jernigan JA.

Health Aff (Millwood). 2014 Jun;33(6):1040-7. doi: 10.1377/hlthaff.2013.0865.

PMID:
24889954
41.

The importance of influenza vaccination.

Babcock HM, Jernigan JA, Relman DA.

JAMA Intern Med. 2014 Apr;174(4):644-5. doi: 10.1001/jamainternmed.2013.11174. No abstract available.

PMID:
24711193
42.

Medicare reimbursement attributable to catheter-associated urinary tract infection in the inpatient setting: a retrospective cohort analysis.

Yi SH, Baggs J, Gould CV, Scott RD 2nd, Jernigan JA.

Med Care. 2014 Jun;52(6):469-78. doi: 10.1097/MLR.0000000000000106.

PMID:
24699236
43.

Activity of commonly used antimicrobial prophylaxis regimens against pathogens causing coronary artery bypass graft and arthroplasty surgical site infections in the United States, 2006-2009.

BerrĂ­os-Torres SI, Yi SH, Bratzler DW, Ma A, Mu Y, Zhu L, Jernigan JA.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):231-9. doi: 10.1086/675289. Epub 2014 Jan 29.

PMID:
24521586
44.

Clinical findings for fungal infections caused by methylprednisolone injections.

Chiller TM, Roy M, Nguyen D, Guh A, Malani AN, Latham R, Peglow S, Kerkering T, Kaufman D, McFadden J, Collins J, Kainer M, Duwve J, Trump D, Blackmore C, Tan C, Cleveland AA, MacCannell T, Muehlenbachs A, Zaki SR, Brandt ME, Jernigan JA; Multistate Fungal Infection Clinical Investigation Team.

N Engl J Med. 2013 Oct 24;369(17):1610-9. doi: 10.1056/NEJMoa1304879.

45.

Targeted versus universal decolonization to prevent ICU infection.

Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program.

N Engl J Med. 2013 Jun 13;368(24):2255-65. doi: 10.1056/NEJMoa1207290. Epub 2013 May 29. Erratum in: N Engl J Med. 2013 Aug 8;369(6):587. N Engl J Med. 2014 Feb 27;370(9):886.

46.

Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report.

Patel PR, Yi SH, Booth S, Bren V, Downham G, Hess S, Kelley K, Lincoln M, Morrissette K, Lindberg C, Jernigan JA, Kallen AJ.

Am J Kidney Dis. 2013 Aug;62(2):322-30. doi: 10.1053/j.ajkd.2013.03.011. Epub 2013 May 13.

PMID:
23676763
47.

National estimates of central line-associated bloodstream infections in critical care patients.

Wise ME, Scott RD 2nd, Baggs JM, Edwards JR, Ellingson KD, Fridkin SK, McDonald LC, Jernigan JA.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):547-54. doi: 10.1086/670629. Epub 2013 Apr 18.

48.

Effect of daily chlorhexidine bathing on hospital-acquired infection.

Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES.

N Engl J Med. 2013 Feb 7;368(6):533-42. doi: 10.1056/NEJMoa1113849. Erratum in: N Engl J Med. 2013 Jun 13;368(24):2341.

49.

Automated hand hygiene count devices may better measure compliance than human observation.

Morgan DJ, Pineles L, Shardell M, Young A, Ellingson K, Jernigan JA, Day HR, Thom KA, Harris AD, Perencevich EN.

Am J Infect Control. 2012 Dec;40(10):955-9. doi: 10.1016/j.ajic.2012.01.026. Epub 2012 May 26.

PMID:
22633134
50.

Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in residents of Veterans Affairs long-term care facilities: role of antimicrobial exposure and MRSA acquisition.

Stone ND, Lewis DR, Johnson TM 2nd, Hartney T, Chandler D, Byrd-Sellers J, McGowan JE Jr, Tenover FC, Jernigan JA, Gaynes RP; Southeast Veterans Affairs Long-Term Care Methicillin-Resistant Staphylococcus aureus Cooperative.

Infect Control Hosp Epidemiol. 2012 Jun;33(6):551-7. doi: 10.1086/665711. Epub 2012 Apr 13.

PMID:
22561709

Supplemental Content

Loading ...
Support Center